Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Glaucoma Suspect Findings
Author Affiliations & Notes
  • Stefania C Maruri
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Qing Wang
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Ives Valenzuela
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Noga Harizman
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Prakash Gorroochurn
    Biostatistics, Columbia University Mailman School of Public Health, New York, New York, United States
  • Desiree R. Henriquez
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Daniel Diamond
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Lisa Park
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jason D. Horowitz
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • James D. Auran
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • David S. Friedman
    Glaucoma Service, Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • C. Gustavo De Moraes
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • George Cioffi
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Jeffrey M Liebmann
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Lisa A. Hark
    Ophthalmology, Columbia University Irving Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   Stefania Maruri None; Qing Wang None; Ives Valenzuela None; Noga Harizman None; Prakash Gorroochurn None; Desiree Henriquez None; Daniel Diamond None; Lisa Park None; Jason Horowitz None; James Auran None; David Friedman None; C. Gustavo De Moraes None; George Cioffi None; Jeffrey Liebmann None; Lisa Hark None
  • Footnotes
    Support  US Centers for Disease Control and Prevention, U01 DP006435 and U01 DP006436 and Research to Prevention Blindness.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 126. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stefania C Maruri, Qing Wang, Ives Valenzuela, Noga Harizman, Prakash Gorroochurn, Desiree R. Henriquez, Daniel Diamond, Lisa Park, Jason D. Horowitz, James D. Auran, David S. Friedman, C. Gustavo De Moraes, George Cioffi, Jeffrey M Liebmann, Lisa A. Hark; Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) Cluster-Randomized Clinical Trial: Subanalysis of Glaucoma Suspect Findings. Invest. Ophthalmol. Vis. Sci. 2023;64(8):126.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe the glaucoma suspect findings from the Manhattan Vision Screening and Follow-up Study, which aims to investigate whether innovative community-based eye health screening using telemedicine can improve early detection and management of glaucoma and other eye diseases among high-risk populations in New York City.

Methods : A 5-year prospective, cluster-randomized clinical trial. Eligible individuals (≥40 years) were recruited from affordable housing buildings and senior centers (≥60 years) in New York City. Participants underwent eye health screening (visual acuity (Snellen), intraocular pressure measurements (IOP), and fundus photography) in community settings. Fundus images were remotely graded by both glaucoma and retina specialists and those with abnormal images were referred to ophthalmology; those who failed the vision screening (visual acuity 20/40 or worse, IOP 23-29 mmHg, or had an unreadable image) were examined by the study optometrist in the community setting. Multivariate logistic regression analysis determined factors associated with odds of referral to ophthalmology for glaucoma suspect from both the telemedicine image reading results and the optometrist eye exam findings.

Results : A total of 708 participants completed the eye health screening from 3/1/21 to 5/31/22; 189 were referred to ophthalmology for suspected glaucoma (26.7%) (138 participants had an abnormal disc image and 51 participants were referred by the optometrist). Mean age of glaucoma suspects: 68.5 years (SD ±11.7), female (60.3.1%), African American (57.1%), and Hispanic (37%). Mean IOP in the worst eye was significantly higher in those referred for suspected glaucoma compared to those not referred (16.1 mmHg vs. 14.4 mmHg) (p<0.05). Multivariate logistic regression analysis showed that participants who had self-identified with pre-existing glaucoma [OR=6.048, 95% CI=(3.560-10.274), p=0.000], had an IOP ≥23 mmHg at the eye health screening [OR=3.210, 95% CI=(1.407-7.323), p=0.006] or needed assistance with transportation [OR=2.081, 95% CI=(1.136-3.815), p=0.018] had higher odds of suspected glaucoma requiring follow-up.

Conclusions : This community-based study targeted high-risk populations, improved access to eye-care, and detected a significant amount of glaucoma suspects requiring referral to ophthalmology.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×